A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375

NCT04221360 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG: CKD-375
DRUG: D390

Sponsor

Chong Kun Dang Pharmaceutical